Award
Veterans Health Administration 11264933
The Tumor Immune Microenvironment in Pancreatic Cancer Chemoresistance
Recipient
Veterans Health Administration
Awarded
December 01, 2025
Identifier
11264933
Research project funded by the Veterans Health Administration to study chemoresistance in pancreatic cancer using advanced molecular techniques and develop a biospecimen program and precision medicine platform for veterans.
Description
This project aims to uncover mechanisms of chemoresistance in pancreatic ductal adenocarcinoma (PDAC) leveraging single-cell RNA sequencing, patient-derived organoid culture, and biospecimen acquisition. It involves the Veterans Health Administration and is funded for the fiscal year 2026. The project will develop a biospecimen program at the Ann Arbor VA and aims to build a precision medicine platform for veterans with pancreatic cancer.